Equity Profile
Post-Earnings Recap
Dyne Therapeutics, Inc.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.25 | $-0.06 | -284.62% |
| Revenue | — | $205M | — |
management commentary, guidance changes, and full analysis available with Pro.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime